Efficacy of HPV vaccine in preventing of increasing cervical lesio

Phase 3

• Conditions: Cervical cancer.; Cervical cancer; C51-C58

• Registration Number: IRCT20190603043801N1
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 242

Inclusion Criteria

Women suffering from various degrees of cervical lesions ( CIN 1, 2, 3)

Exclusion Criteria

Pregnant women
Women with severe allergies

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical finding. Timepoint: At 1, 7, 12, 18, 24 months. Method of measurement: Gynecological examination.;Pap tests results. Timepoint: At 1, 7, 12, 24 months. Method of measurement: Pap smear Testing.